Press Releases

All Releases
Sep 22, 2011
Scott Solano to Depart AngioDynamics
ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced that Scott Solano , Senior Vice President and Chief Technology Officer, has resigned
Sep 12, 2011
AngioDynamics Names Alan Panzer SVP, GM of Vascular Division
ALBANY, N.Y. , Sept. 12, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, has appointed Alan Panzer , 50, as Senior Vice President and General Manager of
Aug 16, 2011
AngioDynamics Names Joseph M. DeVivo President and CEO
ALBANY, N.Y. --(BUSINESS WIRE)-- The Board of Directors of AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, appointed Joseph M. DeVivo President and Chief Executive Officer,
May 24, 2011
AngioDynamics Reports Oncology/Surgery Division Developments
U.S. distribution contract for LC Beads ™ to expire on December 31, 2011 FDA approves IDE for NanoKnife ® System study in prostate cancer Company expects to submit IDE for NanoKnife System study in pancreatic cancer by mid-June Oncology/Surgery division to enhance focus on NanoKnife, and
Apr 20, 2011
AngioDynamics to Present at Upcoming Investor Conferences in May 2011
ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that executive management will present at the following investor conferences in
Displaying 261 - 280 of 686